Erratum: Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain
- PMID: 20046848
- PMCID: PMC2798986
- DOI: 10.1007/s12177-009-9033-7
Erratum: Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain
Abstract
Given the advantages of being stable in the ambient environment, being permeable to the blood-brain and/or blood-eye barriers and being convenient for administration, naturopathic compounds have growingly become promising therapeutic candidates for neural protection. Extracted from one of the most common Chinese herbal medicines, tetramethylpyrazine (TMP), also designated as ligustrazine, has been suggested to be neuroprotective in the central nervous system as well as the peripheral nerve network. Although the detailed molecular mechanisms of its efficacy for neural protection are understood limitedly, accumulating evidence suggests that antioxidative stress, antagonism for calcium, and suppression of pro-inflammatory factors contribute significantly to its neuroprotection. In animal studies, systemic administration of TMP (subcutaneous injection, 50 mg/kg) significantly blocked neuronal degeneration in hippocampus as well as the other vulnerable regions in brains of Sprague-Dawley rats following kainate-induced prolonged seizures. Results from us and others also demonstrated potent neuroprotective efficacy of TMP for retinal cells and robust benefits for brain in Alzheimer's disease or other brain injury. These results suggest a promising prospect for TMP to be used as a treatment of specific neurodegenerative diseases. Given the assessment of the distribution, metabolism, excretion, and toxicity information that is already available on most neuroprotective naturopathic compounds such as TMP, preclinical data to justify bringing such therapeutic compounds to clinical trials in humans is feasible.[This corrects the article on p. in vol. .].
Figures


Erratum for
-
Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.J Ocul Biol Dis Infor. 2009 Jun;2(2):57-64. doi: 10.1007/s12177-009-9024-8. Epub 2009 Jul 14. J Ocul Biol Dis Infor. 2009. PMID: 19672463 Free PMC article.
Similar articles
-
Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.J Ocul Biol Dis Infor. 2009 Jun;2(2):57-64. doi: 10.1007/s12177-009-9024-8. Epub 2009 Jul 14. J Ocul Biol Dis Infor. 2009. PMID: 19672463 Free PMC article.
-
Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats.Neurochem Int. 2006 Feb;48(3):166-76. doi: 10.1016/j.neuint.2005.10.008. Epub 2005 Nov 28. Neurochem Int. 2006. PMID: 16316708
-
Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury.J Ethnopharmacol. 2015 Dec 4;175:638-47. doi: 10.1016/j.jep.2015.09.034. Epub 2015 Oct 3. J Ethnopharmacol. 2015. PMID: 26435225
-
Neuroprotection by tetramethylpyrazine and its synthesized analogues for central nervous system diseases: a review.Mol Biol Rep. 2024 Jan 22;51(1):159. doi: 10.1007/s11033-023-09068-y. Mol Biol Rep. 2024. PMID: 38252346 Review.
-
Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review.Front Pharmacol. 2022 Sep 5;13:948600. doi: 10.3389/fphar.2022.948600. eCollection 2022. Front Pharmacol. 2022. PMID: 36133805 Free PMC article. Review.
Cited by
-
Ligustrazine monomer against cerebral ischemia/reperfusion injury.Neural Regen Res. 2015 May;10(5):832-40. doi: 10.4103/1673-5374.156991. Neural Regen Res. 2015. PMID: 26109963 Free PMC article. Review.
-
Tetramethylpyrazine Improves Cognitive Function of Alzheimer's Disease Mice by Regulating SSTR4 Ubiquitination.Drug Des Devel Ther. 2021 Jun 1;15:2385-2399. doi: 10.2147/DDDT.S290030. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34103899 Free PMC article.
-
TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2157-69. doi: 10.1167/iovs.11-9315. Invest Ophthalmol Vis Sci. 2012. PMID: 22410554 Free PMC article.
References
-
- Mattson MP. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal. 2006;8:1997–2006. - PubMed
-
- Kazantsev AG. Cellular pathways leading to neuronal dysfunction and degeneration. Drug News Perspect. 2007;20:501–509. - PubMed
-
- Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience. 2007;145:1233–1248. - PubMed
-
- Liu YH, Liu YF, Guo XX. Current studies on anti-endotoxic chemical components of traditional Chinese medicine in China. Acta Pharmacologica Sinica. 2001;22:1071–1077. - PubMed
Publication types
LinkOut - more resources
Full Text Sources